✦ LIBER ✦

Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma : Results of a large phase 2 study

✍ Scribed by David J. Vaughn; Sandy Srinivas; Walter M. Stadler; Roberto Pili; Daniel Petrylak; Cora N. Sternberg; David C. Smith; Sarah Ringuette; Edwin de Wit; Virginie Pautret; Claude George

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 162 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24460

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, open-label study of gefitini

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

✍ Monika Jermann; Rolf A Stahel; Marc Salzberg; Thomas Cerny; Markus Joerger; Silk 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 226 KB

A phase II study of capecitabine plus ge

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

✍ Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB

A phase II study of pemetrexed and carbo

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer

✍ August Garin; Alexey Manikhas; Mikhail Biakhov; Mikhail Chezhin; Tatiana Ivanche 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB

A single-arm, multicenter, open-label ph

A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

✍ Christian Wülfing; Jean-Pascal H. Machiels; Dirk J. Richel; Marc-Oliver Grimm; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##

Results of a phase II study of pemetrexe

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB